Skip to main content
. 2015 Sep 8;59:10.3402/fnr.v59.28551. doi: 10.3402/fnr.v59.28551

Table 2.

Dietary intakes of the pomegranate juice and placebo groupsa

Intake Groups Baseline Week 12
Energy (kcal/d) Pomegranate 1,784±238b 1,787±233b
Placebo 2,028±241 2,011±221
Protein (g/d) Pomegranate 54±12 58±12
Placebo 59±10 65±9
Carbohydrate (g/d) Pomegranate 234±35 266±41b
Placebo 232±27 257±37
Fiber (g/d) Pomegranate 15±4 15±3
Placebo 16±3 15±4
Fat (g/d) Pomegranate 73±20 72±19
Placebo 84±15 83±19
SAFA (g/d) Pomegranate 16.2±5.5 17.2±6.4
Placebo 23.7±8.8 21.3±8.2
MUFA (g/d) Pomegranate 30.7±11 29.8±8.8
Placebo 32.5±6.1 33.6±8.7
PUFA (g/d) Pomegranate 21.4±6.7 19.4±4.4
Placebo 20.5±6.1 21.7±5.9
Cholesterol (mg/d) Pomegranate 134.3±60.7 136.1±48.6
Placebo 169.6±78 189.9±58.2
Vitamin E (mg/d) Pomegranate 22.7±5.9 20.7±4.7
Placebo 20.5±6.6 22.1±6.6
Vitamin C (mg/d) Pomegranate 78.7±54.3 77.3±32.9
Placebo 60.1±32.8 66.6±32.1
Vitamin A (μg/d) Pomegranate 559.7±478.3 719.9±609
Placebo 440.8±349.4 359.7±170.2

BMI: body mass index; MUFA: monounsaturated fatty acids; SAFA: saturated fatty acids; PUFA: polyunsaturated fatty acids.

All values are presented as mean±SD.

a

n=22 for all values.

b

P<0.05 versus the placebo group.